These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35142298)

  • 1. Seroprevalence of SARS-CoV-2 and assessment of epidemiologic determinants in Portuguese municipal workers.
    Barros Ferreira N; Pereira H; Pereira AM; Azevedo LF; Santos M; Maranhão P; Correia R; Fonseca JA; Canedo P; da Costa Pereira A; Sousa-Pinto B
    Int J Occup Med Environ Health; 2022 Jun; 35(3):297-307. PubMed ID: 35142298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of SARS-CoV-2 in a Large Cohort of Italian Police Officers.
    Garbarino S; Domnich A; Costa E; Giberti I; Mosca S; Belfiore C; Ciprani F; Icardi G
    Int J Environ Res Public Health; 2021 Nov; 18(22):. PubMed ID: 34831958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 seroprevalence in healthcare workers of a teaching hospital in a highly endemic region in the Netherlands after the first wave: a cross-sectional study.
    Bouwman M; van Osch F; Crijns F; Trienekens T; Mehagnoul-Schipper J; van den Bergh JP; de Vries J
    BMJ Open; 2021 Oct; 11(10):e051573. PubMed ID: 34663664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of anti-SARS-CoV-2 antibodies in the Northern Italy population before the COVID-19 second wave.
    Berselli N; Filippini T; Paduano S; Malavolti M; Modenese A; Gobba F; Borella P; Marchesi I; Vivoli R; Perlini P; Bellucci R; Bargellini A; Vinceti M
    Int J Occup Med Environ Health; 2022 Feb; 35(1):63-74. PubMed ID: 34524275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Antibody Prevalence in the Portuguese Municipality of Vila Nova de Gaia after the First Wave of the Pandemic.
    De Carvalho Á; Virgolino A; Queirós P; Henriques AR; Canhão H; Rodrigues AM; Barbosa V; Rodrigues J; Germano de Sousa J; Guimarães M
    Acta Med Port; 2022 Jun; 35(6):468-475. PubMed ID: 36279518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection among Veterans Affairs healthcare system employees suggests higher risk of infection when exposed to SARS-CoV-2 outside the work environment.
    Dimcheff DE; Schildhouse RJ; Hausman MS; Vincent BM; Markovitz E; Chensue SW; Deng J; McLeod M; Hagan D; Russell J; Bradley SF
    Infect Control Hosp Epidemiol; 2021 Apr; 42(4):392-398. PubMed ID: 32962771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of and Risk Factors Associated With SARS-CoV-2 Infection in Health Care Workers During the Early COVID-19 Pandemic in Italy.
    Poletti P; Tirani M; Cereda D; Guzzetta G; Trentini F; Marziano V; Toso C; Piatti A; Piccarreta R; Melegaro A; Andreassi A; Gramegna M; Ajelli M; Merler S
    JAMA Netw Open; 2021 Jul; 4(7):e2115699. PubMed ID: 34228126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 seroprevalence in hospital healthcare workers in Western Switzerland at the end of the second pandemic wave.
    Jacot D; von Rotz U; Blondet F; Aebischer O; Matthieu P; De Rham M; Pantaleo G; Marchetti O; Greub G
    J Med Microbiol; 2022 Aug; 71(8):. PubMed ID: 35921229
    [No Abstract]   [Full Text] [Related]  

  • 9. Determinants of seropositivity for SARS-CoV-2 in hospital staff in the second wave of the pandemic in Slovenia.
    Socan M; Prosenc K; Kukec A; Zaletel-Kragelj L; Remec T; Grmek-Kosnik I
    Int J Occup Med Environ Health; 2022 Oct; 35(5):571-584. PubMed ID: 35856815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 seroprevalence in Portugal following the third epidemic wave: results of the second National Serological Survey (ISN2COVID-19).
    Kislaya I; Gonçalves P; Gómez V; Gaio V; Roquette R; Barreto M; Sousa-Uva M; Torres AR; Santos J; Matos R; Manita C; Almeida Santos J; Soeiro S; de Sousa R; Costa I; Verdasca N; Guiomar R; Rodrigues AP;
    Infect Dis (Lond); 2022 Jun; 54(6):418-424. PubMed ID: 35023439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence and longevity of SARS-CoV-2 nucleocapsid antigen-IgG among health care workers in a large COVID-19 public hospital in Saudi Arabia: A prospective cohort study.
    Alasmari F; Mukahal M; Alqurashi AA; Huq M; Alabdrabalnabi F; AlJurayyan A; Alkahtani SM; Assari FS; Bashaweeh R; Salam R; Aldera S; Alkinani OM; Almutairi T; AlEnizi K; Tleyjeh I
    PLoS One; 2022; 17(8):e0272818. PubMed ID: 35960736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain.
    Peremiquel-Trillas P; Saura-Lázaro A; Benavente-Moreno Y; Casabonne D; Loureiro E; Cabrera S; Duran A; Garrote L; Brao I; Trelis J; Galán M; Soler F; Julià J; Cortasa D; Domínguez MÁ; Albasanz-Puig A; Gudiol C; Ramírez-Tarruella D; Muniesa J; Rivas JP; Muñoz-Montplet C; Sedano A; Plans À; Calvo-Cerrada B; Calle C; Clopés A; Carnicer-Pont D; Alemany L; Fernández E
    BMJ Open; 2022 Apr; 12(4):e056637. PubMed ID: 35450905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
    Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
    Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of SARS-CoV-2 antibodies in over 6000 healthcare workers in Spain.
    Varona JF; Madurga R; Peñalver F; Abarca E; Almirall C; Cruz M; Ramos E; Castellano Vázquez JM
    Int J Epidemiol; 2021 May; 50(2):400-409. PubMed ID: 33434269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Seroprevalence Following a Large-Scale Vaccination Campaign in Portugal: Results of the National Serological Survey, September - November 2021.
    Kislaya I; Gonçalves P; Ramalhete S; Barreto M; Torres AR; Gaio V; Gómez V; Manita C; Almeida Santos J; Soeiro S; De Sousa R; Melo A; Henriques C; Guiomar R; Rodrigues AP;
    Acta Med Port; 2023 Jan; 36(1):5-14. PubMed ID: 36288645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-sectional study evaluating the seroprevalence of SARS-CoV-2 antibodies among healthcare workers and factors associated with exposure during the first wave of the COVID-19 pandemic in New York.
    Bryan A; Tatem K; Diuguid-Gerber J; Cooke C; Romanoff A; Choudhury N; Scanlon M; Kishore P; Sydney E; Masci J; Bakshi P; Pemmasani S; Davis NJ; Maru D
    BMJ Open; 2021 Nov; 11(11):e053158. PubMed ID: 34732494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 seroprevalence and antibodies persistence among health care workers after the first COVID-19 wave in nine hospitals in Western France.
    Garlantezec R; Tadié E; Heslan C; Gary-Bobo P; Oumari S; Saade A; Sitruk A; Tattevin P; Thibault V; Paris C;
    Infect Dis Now; 2022 Nov; 52(8):447-452. PubMed ID: 36108975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The seroprevalence of SARS-CoV-2 in a rural southwest community.
    Santarelli A; Lalitsasivimol D; Bartholomew N; Reid S; Reid J; Lyon C; Wells J; Ashurst J
    J Osteopath Med; 2021 Feb; 121(2):199-210. PubMed ID: 33567087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the prevalence of anti-SARS-CoV-2 antibodies in groups of medical and non-medical professions.
    Biernacka P; Piekarska A; Berkan-Kawińska A
    Int J Occup Med Environ Health; 2023 Nov; 36(5):643-655. PubMed ID: 37768026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of Anti-SARS-CoV-2 Antibodies among Municipal Staff in the Municipality of Prishtina.
    Gashi B; Osmani V; Halili R; Hoxha T; Kamberi A; Hoti N; Agahi R; Basha V; Berisha V; Hoxha I
    Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.